Wrenches in the works: drug discovery targeting the SCF ubiquitin ligase and APC/C complexes

Timothy Cardozo1, Michele Pagano

  • 1Department of Pharmacology NYU Cancer Institute, New York University School of Medicine, 550 First Avenue MSB 599, New York, NY 10016, USA. timc@saturn.med.nyu.edu

BMC Biochemistry
|December 6, 2007
PubMed

Insights

The ubiquitin proteasome system (UPS) is a key drug target. Modulating specific E3 ubiquitin ligases, like SCFSkp2 and APC/C, offers potential for improved cancer therapeutics beyond current proteasome inhibitors.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • The ubiquitin proteasome system (UPS) is crucial for cellular protein degradation.
  • Proteasome inhibitors like Velcade show clinical efficacy in multiple myeloma.
  • Specificity in UPS-mediated degradation is determined by E3 ubiquitin ligases.

Purpose of the Study:

  • To review the drug development potential of key UPS targets.
  • To assess SCFSkp2 and APC/C as therapeutic targets.
  • To explore the biological rationale, assays, and structural data for UPS targets.

Main Methods:

  • Literature review of biological rationale, genomics, proteomics, and 3D structures.
  • Analysis of E3 ubiquitin ligase function and substrate specificity.
  • Evaluation of drug development potential for UPS targets.

Main Results:

  • The UPS is a validated drug discovery arena.
  • Modulating specific E3 ligases may offer better therapeutic ratios than broad proteasome inhibition.
  • SCFSkp2 and APC/C are identified as key targets for UPS-based drug development.

Conclusions:

  • Targeting specific E3 ubiquitin ligases within the UPS presents a promising strategy for novel therapeutics.
  • Further research into SCFSkp2 and APC/C could lead to new cancer treatments.
  • The UPS continues to be a fertile ground for developing targeted protein degradation therapies.

Related Concept Videos

Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...